Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
life sciences
national blog main
9
×
startups
boston blog main
boston top stories
national top stories
new york blog main
san francisco blog main
new york top stories
san diego blog main
san diego top stories
san francisco top stories
boulder/denver blog main
boston
boulder/denver top stories
clinical trials
deals
detroit blog main
detroit top stories
financing
indiana blog main
indiana top stories
investing
national
raleigh-durham blog main
raleigh-durham top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
vc
venture capital
wisconsin blog main
wisconsin top stories
amgen
cancer
drugs
eli lilly
fda
What
drugs
9
×
new
9
×
drug
medicines
neuro
advance
aims
ceo
companies
develop
developing
diseases
raised
raises
research
therapies
adds
analyzes
approach
approval
arguments
associated
backed
bails
based
big
bio
biologic
biologics
biology
biotech
brand
bridgebio
called
capital
car
cause
cholesterol
class
commercialized
Language
unset
Current search:
new
×
drugs
×
" national blog main "
×
@xconomy.com
3 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
4 years ago
EnClear Therapies Nets $10M to Test Neuro Disease ‘Dialysis’ Device
@xconomy.com
4 years ago
DTx Pharma Raises $10.6M to Advance New Way to Deliver RNA Drugs
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
4 years ago
New PCSK9 Cholesterol Drug Faces Tough Foe. (Hint: Not Cholesterol.)
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
Verana Health Lands $30M Financing Led By GV, Adds Miki Kapoor as CEO
@xconomy.com
6 years ago
Synthorx Raises $63M to Advance Suite of Enhanced Cytokine Drugs